1 min read
Add as a preferred source on Google

Merck Teams Up With Isomorphic Labs to Discover Cancer Drug Candidates

Isomorphic Labs will use its IsoDDE drug-design engine and data supplied by Merck in the collaboration announced Thursday.

A clear vial stands beside a molecular model in a laboratory / TokenPost.ai (mono)
A clear vial stands beside a molecular model in a laboratory / TokenPost.ai (mono)

Merck and Isomorphic Labs are collaborating to discover drug candidates against cancer, combining the pharmaceutical company’s data with Isomorphic Labs’ AI drug-design engine.

Isomorphic Labs will use its engine, IsoDDE, along with data supplied by Merck. The companies announced the collaboration Thursday.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…